ROCKWELL MEDICAL, INC. Deferred Tax Assets, Tax Deferred Expense, Other
ROCKWELL MEDICAL, INC. (RMTI) had Deferred Tax Assets, Tax Deferred Expense, Other of $244.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $244.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $65.00K; Deferred Tax Assets, Tax Deferred Expense, Other as first filed $1.97M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $1.99M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $1.27M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other | Deferred Tax Assets, Tax Deferred Expense, Other as first filed |
|---|---|---|
| 2025-12-31 | $244.00K 10-K · filed 2026-03-26 | |
| 2024-12-31 | $65.00K 10-K · filed 2026-03-26 | $1.97M 10-K · filed 2025-03-20 |
| 2023-12-31 | $1.99M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $1.27M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $865.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $387.00K 10-K · filed 2022-04-08 | |
| 2019-12-31 | $22.00K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |